Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Nobilis Health Corp. N.HLTH

Alternate Symbol(s):  NRTSF

Nobilis Health Corp is a full-service healthcare development and management company. It owns and operates healthcare centers and facilities and provides minimally invasive procedures to patients and also utilizes direct to patient marketing and proprietary technologies to drive patient engagement and education. The firm also provides its services to its medical facilities as well as to third parties as a stand-alone service. The company has Medical and Marketing reportable business segments and


NEO:HLTH - Post by User

Bullboard Posts
Comment by LAG4on Aug 08, 2018 12:24pm
205 Views
Post# 28427752

RE:Q2 conference call

RE:Q2 conference callInteresting exchange and thanks for bringing this up. I have a question in regard to this. The 144 million AR that's outstanding, is that already booked in as earnings for the various quarters or is it added in if and when they collect it. If so if they manage to drop that number down to 124 million as stated does that 20 million come in as profit or is it already accounted for as profit. Thanks.
theinvestor22 wrote: I might have more to say later, but I did find the exchange between Neil Goldman of Goldman Capital Management and Nobilis particularly interesting. The first part is good clarification on what seems like a guidance decrease (see ASC 606) and the second relates to the actions being taken by the company on A/R collection. Personally, I think the jury is still out on the latter, but at least it's something...

Neil Goldman of Goldman Capital Management: “...If I take the receivable write-off of five eight [US$5.8M] which you didn't expect obviously in the original [guidance] you would've had increase in earnings...EBITDA over what you originally forecasted. It would've been sixty one point eight to sixty four point two and you were [originally at an EBITDA guidance of] fifty seven to sixty two if I remember."
 
Nobilis: “Yes, absolutely.”
 
Goldman: “And, so, the margins are significantly better by definition than the...”
 
Nobilis: “That's right.”
 
Goldman:  “Okay. The receivable today is how much?”
 
Nobilis: “144 million...143 and a half."
 
Goldman: “And what would be your expectation in terms of reduction in the second half?”
 
Nobilis: “We're talking about, about a 20 million dollar reduction in the second half.
 
Goldman: “Are there plans to achieve that, or where's that coming from?”
 
Nobilis: “I do think we have. We've got some new leadership there.  We're working with some third parties who are specialists on out-of-network collections and post ?? processes and we feel good about the results we're starting to see.  We're already starting to see improvement there.”
 
Goldman: “So that would be a significant change in the fourth quarter also?”
 
Nobilis: “It would be.”


Bullboard Posts